Angel Pharmaceuticals

Focus: Angel Pharmaceuticals is a early-stage Chinese biotech founded in 2021 focused on small molecules and biologics across neurology and adjacent therapeutic areas. The company operates from Zhejiang with minimal public scale data available.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Angel Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Angel Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Labor Induction

Pre-Eclampsia

N/A

Clinical Trials (1)

NCT05056467Labor Induction in Preeclampsia High-risk Women

N/A

Help build intelligence for Angel Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity to shape drug development strategy at a newly founded company with 14 pipeline programs across multiple modalities
Exposure to diverse therapeutic areas including neurology, oncology, and rare diseases with Phase 3 assets (Guardian System for ACS) showing clinical advancement
Ground-floor position at a China-based biotech with potential access to Asian regulatory pathways and emerging markets

Watch Out For

Extreme pipeline incoherence—programs span weighted blankets, diet interventions, and devices alongside pharmaceuticals, suggesting unclear strategic focus or data quality issues
No disclosed funding, revenue, cash position, or employee count raises fundamental questions about capitalization, burn rate, and runway sustainability
Only 1 active job opening and no H1B sponsorship track record limits hiring scale and international mobility

Generated by Claude from Angel Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

PMA P150009 AngelMed Guardian® System

Acute Coronary Syndrome

N/A

Clinical Trials (1)

NCT05412927AngelMed Guardian® System PMA Post Approval Study

N/A

LMHF mechanical stimulation active device

Bone Mineral Density

N/A

Dietary Intervention

B Precursor Type Acute Leukemia

N/A

Polyurethane expandable valve stent

Valvulopathy

N/A

Clinical Trials (1)

NCT05289622Stent Implantation of Polyurethane Expandable Valve, by Catheter, in Patients With Pulmonary Valve Dysfunction

N/A

LMHF mechanical stimulation device

Bone Mineral Density

N/A

Weighted Blanket

Hematological Malignancies

N/A

Clinical Trials (1)

NCT06584955Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies

N/A

Fibrinogen Concentrate Human

Postpartum Hemorrhage

N/A

Clinical Trials (1)

NCT03784794Patient Blood Management for Massive Obstetric Hemorrhage

N/A

Low Glycemic Index Diet

Acute Lymphoblastic Leukemia, Pediatric

N/A

Clinical Trials (1)

NCT03157323Low GI Diet in Children and Adolescents With ALL

N/A

Virtual Diabetes Wellness Classes and Medically Tailored Meals

Diabetes

N/A

Clinical Trials (1)

NCT05088616Native American Diabetes Project

N/A

CKD progression biomarker

Chronic Kidney Disease

N/A

Clinical Trials (1)

NCT06962891Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease

N/A

Community Service-Learning Anthropometric Assessment

Medical Education

N/A

Clinical Trials (1)

NCT07528521Effect of a Community Service-Learning Intervention on Medical Empathy and Clinical Self-Efficacy in Medical Students

N/A

Tranylcypromine

Acute Myelogenous Leukemia

Phase 1

Clinical Trials (1)

NCT02273102Study of TCP-ATRA for Adult Patients With AML and MDS

Phase 1

Nintedanib

Breast Cancer

Phase 1

Clinical Trials (1)

NCT02619162Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics

Phase 1

Fludarabine

Leukemia, Myeloid, Acute

Phase 1/2

Hyperbaric Oxygen

Covid-19

Phase 2

Clinical Trials (1)

NCT04477954Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia

Phase 2

Uric Acid

Acute Ischemic Stroke

Phase 2/3

Clinical Trials (1)

NCT00860366Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke

Phase 2/3

Guardian System

Acute Coronary Syndrome

Phase 3

Clinical Trials (2)

NCT00781118AngelMed for Early Recognition and Treatment of STEMI

Phase 3

NCT04316481IDE-ALERTS Continued Access Study

N/A

Nonavalent HPV vaccine

Human Papillomavirus Infections

Phase 4

Clinical Trials (1)

NCT05334706A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Phase 4